Загрузка...
Therapeutic advances in the management of Pompe disease and other metabolic myopathies
The world of metabolic myopathies has been dramatically modified by the advent of enzyme replacement therapy (ERT), the first causative treatment for glycogenosis type II (GSDII) or Pompe disease, which has given new impetus to research into that disease and also other pathologies. This article revi...
Сохранить в:
| Главные авторы: | , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
SAGE Publications
2013
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3755530/ https://ncbi.nlm.nih.gov/pubmed/23997816 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756285613487570 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|